Cultural Taboos and Shame Leave Vulvar Skin Disease Undiagnosed in Women of Color

A new review published in the Archives of Dermatological Research argues that vulvar dermatoses, a group of chronic inflammatory skin conditions affecting the external genitalia, are being systematically underdiagnosed and undertreated in women with skin of color, and that the reasons extend far beyond the clinic. The authors, led by Grace Herrick of the Alabama College of Osteopathic Medicine and Harleen K. Multani of Meharry Medical College School of Medicine, contend that cultural taboos, patient shame, provider discomfort, and diagnostic frameworks built around lighter skin converge to create a compounding delay in care. The review, published on 28 September 2026, frames the problem as an intersection of culture, structure, and education rather than a simple failure of clinical vigilance.

Vulvar dermatoses encompass conditions such as lichen sclerosus, lichen planus, lichen simplex chronicus, and eczematous or contact dermatitis affecting the vulvar skin. Many of these disorders are chronic and benign, but they can cause intense itching, pain, scarring, and architectural change to the vulvar tissue, with profound effects on sexual function and quality of life. Early diagnosis matters because treatments such as topical corticosteroids can control inflammation and prevent long-term scarring, particularly in lichen sclerosus, which is associated with irreversible structural damage when left unchecked. The review emphasizes that when these conditions are missed or misclassified, patients may endure years of symptoms before receiving an accurate diagnosis.

The authors argue that the first barrier is linguistic and cultural. In many communities of color, they write, discussions of vulvar health remain taboo, constrained by norms that associate the genital region with moral impurity. This silence has measurable consequences: women may never develop the vocabulary to describe their symptoms, may not know that their symptoms constitute a treatable medical condition, and may feel that raising such concerns with a clinician is itself shameful. The review draws on qualitative research showing that in some migrant and refugee communities, sexual and reproductive health topics are simply not discussed, and that parent-adolescent communication about these subjects is often absent, leaving girls and women without a framework for understanding their own bodies.

Shame operates on an internal level as well. The review cites studies of women living with chronic vulvar dermatoses that describe feelings of loss, secrecy, and embarrassment, and broader psychological research linking internalized body stigma to avoidance of preventive healthcare. When a condition affects a body region already surrounded by cultural discomfort, the review suggests, the psychological cost of seeking care rises sharply. Women may delay presentation until symptoms become unbearable, by which point scarring or secondary changes such as lichen simplex chronicus, a thickening of the skin caused by chronic scratching, may already be established. The authors also point to documented experiences of patients with vulvovaginal disorders who report feeling dismissed or disbelieved by clinicians, a pattern described in recent literature as medical gaslighting, which further discourages help-seeking.

Mistrust in the healthcare system forms the second major barrier. The review situates vulvar dermatoses within the broader context of racialized dismissal in medicine, citing well-documented evidence that pain in Black patients is systematically undertreated and that false beliefs about biological differences between Black and white patients persist among some clinicians. For women of color, the decision to disclose intimate symptoms requires trust that the disclosure will be met with competence and respect. The authors argue that longstanding patterns of dismissal, combined with inadequate recognition of dermatologic symptoms in richly pigmented skin, erode that trust and create a rational basis for diagnostic avoidance on the patient’s side.

The third barrier lies within the clinic itself. The review reports that providers express discomfort and insufficient training in evaluating vulvar dermatoses, particularly on darker skin tones. Dermatology’s visual diagnostic tradition relies on recognizing erythema, or redness, as a hallmark of inflammation, but in deeply pigmented skin, inflammation often presents instead as hyperpigmentation, hypopigmentation, or subtle textural change. Diagnostic frameworks and clinical imagery have historically been built around lighter phototypes, and the review cites analyses showing that medical textbook imagery underrepresents darker skin tones. The result is a systematic mismatch: pigmentary changes may be misclassified, inflammation may be underrecognized, and chronic disorders such as lichen sclerosus and lichen planus may be missed entirely.

The consequences of this mismatch are not hypothetical. The review highlights a scoping assessment of lichen sclerosus treatment studies that found women of color were underrepresented in the evidence base, meaning that even the clinical trials guiding therapy may not reflect the populations most likely to be missed. Survey studies of primary care in the United Kingdom have documented substantial barriers to identifying and treating vulval lichen sclerosus, including delayed referral and limited clinician confidence, and the authors argue that these barriers are amplified for patients whose disease presentation deviates from textbook descriptions. Diagnostic delay in lichen sclerosus is clinically significant because untreated disease can cause loss of vulvar architecture, scarring that narrows the vaginal opening, and an increased risk of squamous cell carcinoma in a minority of cases.

The review also examines how hygiene practices and health communication shape presentation. Multigenerational studies of vaginal hygiene messaging among Black women show that hygiene advice is passed down within families, sometimes emphasizing practices that may exacerbate rather than soothe dermatologic disease, such as aggressive washing or the use of products that disrupt the skin barrier. Research on immigrant Hispanic women, Iraqi Muslim women, and Mexican heritage women in the United States documents how acculturation, language barriers, and differing cultural expectations around modesty influence whether and how women engage with healthcare providers about intimate concerns. The authors argue that clinicians who understand these contexts can frame examinations and treatment plans in ways that patients find acceptable, while clinicians who do not may inadvertently alienate the very patients most at risk of delayed diagnosis.

What emerges from the review is a model in which patient shame, provider discomfort, and non-inclusive diagnostic criteria reinforce one another. A woman reluctant to discuss symptoms encounters a clinician who is himself or herself uncomfortable with the examination and trained on imagery that does not resemble the patient in front of them. The encounter produces an inconclusive or dismissive result, which validates the patient’s initial reluctance and deepens her mistrust. The authors describe this as a cycle in which each failed encounter raises the threshold for the next attempt at care. Breaking the cycle, they argue, requires intervention at every point: normalizing vulvar health conversations within communities, training clinicians to examine and describe disease in all skin tones, and expanding the visual and textual resources available for education and diagnosis.

The review concludes that addressing these disparities requires more than improved clinical instruction; it calls for what the authors describe as a fundamental reorientation of how dermatology approaches genital health in historically marginalized populations. They call for culturally sensitive educational resources developed with patient and public input, and for affirming the validity of vulvar concerns regardless of skin tone. The technical implications are concrete: broader representation of vulvar dermatoses in clinical imagery across the Fitzpatrick phototype spectrum, explicit teaching of how inflammation and pigmentary change manifest in richly pigmented skin, and inclusion of women of color in treatment studies so that evidence-based recommendations rest on representative data. For a field whose diagnostic power depends on pattern recognition, the review is a reminder that patterns can only be recognized if they have been seen, taught, and documented, and that the silence surrounding vulvar health in many communities is not a cultural curiosity but a measurable driver of disease burden.

Subject of Research: Cultural and systemic barriers to diagnosis of vulvar dermatoses in women with skin of color

Article Title: Cultural taboos, shame, and diagnostic avoidance in vulvar dermatoses among women with skin of color

Article References: Herrick, G., Multani, H. K., Rizzo, D., Sraa, K., Edupuganti, N., Click, K., Prajapati, S., Frasier, K., Dempsey, K., & Shah, P. R. (2026). Cultural taboos, shame, and diagnostic avoidance in vulvar dermatoses among women with skin of color. Archives of Dermatological Research, 318(1), Article 495. https://doi.org/10.1007/s00403-026-04995-9

Image Credits: AI Generated

DOI: 10.1007/s00403-026-04995-9

Keywords: vulvar dermatoses, skin of color, lichen sclerosus, lichen planus, cultural taboos, health disparities, diagnostic delay, medical gaslighting, dermatology, women's health, health equity, pigmented skin